J.P. Morgan reduces its stake in SINOPHARM (01099) by approximately 1.22 million shares, with a price of around HK$19.87 per share.
On February 18, J.P. Morgan reduced its holdings in China National Pharmaceutical Group Corporation (01099) by 1,221,708 shares, with each share priced at HK$19.8733.
According to the latest data from the Hong Kong Stock Exchange, on February 18th, J.P. Morgan reduced its holdings of SINOPHARM (01099) by 1,221,708 shares, with an average price of HK$19.8733 per share, for a total amount of approximately HK$24.2794 million. After the reduction, the latest number of shares held is approximately 107 million shares, and the latest shareholding ratio is 7.96%.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
